1. Andersin, T., Väisänen, S. and Carlberg,
C. The critical role of carboxy-terminal amino acids in
ligand-dependent and -independent transactivation of the constitutive
androstane receptor. (2003) Mol. Endocrinol. 17, 234-246 (Impact
factor2003 5.7). PDF-FILE
2. Carlberg, C. Molecular basis of the selective activity of vitamin
D analogues. (2003) J. Cell Biochem. 88, 274-281 (Impact factor2003
2.5). PDF-FILE
3. Väisänen, S., Peräkylä, M., Kärkkäinen, J.I., Uskokovic, M.R. and
Carlberg, C. Structural evaluation of a vitamin D analogue with two
side chains. (2003) Mol. Pharmacol. 63, 1230-1237 (Impact factor2003
5.7). PDF-FILE
4. Carlberg, C. and Mouriño, A. Vitamin D receptor ligands.
(2003) Exp. Opin. Ther. Patents 13, 761-772 (Impact factor2003
1.6). PDF-FILE
5. Macias Gonzalez, M., Samenfeld, P., Peräkylä, M. and Carlberg, C.
Corepressor excess shifts the two side chain vitamin D analogue Gemini from
an agonist to an inverse agonist of the vitamin D receptor. (2003) Mol.
Endocrinol. 17, 2028-2038 (Impact factor2003 5.7).
PDF-FILE
6. Carlberg, C. Current understanding of the function of the
nuclear vitamin D receptor in response to its natural and synthetic ligands.
(2003) Vitamin D Analogs in Cancer Prevention and Therapy, Reichart, J.,
(ed.), Recent Results in Cancer Research 164, 29-42.
PDF-FILE
7. Frank, C., Macias Gonzalez, M., Oinonen, C., Dunlop, T.W. and
Carlberg, C. Characterization of DNA complexes formed byt the nuclear
receptor constitutive androstane receptor. (2003) J. Biol. Chem.
278, 43299-43310 (Impact factor2003 6.5.
PDF-FILE |
|
|
|
